Purchase Order 75F40122P00518
Award Date 9/18/22
Potential Completion Date 9/17/23
Potential Value $733K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Billerica, MA 01821, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $126,772 firm fixed price purchase order to Bruker Biospin Corp. to deliver a solid-state NMR probe. The place of performance is in Billerica, Massachusetts, with work expected to be completed by April 2024. Per the solicitation, the FDA requested quotes for a solid-state NMR probe to add to an existing 500-MHz instrument in order to expand its analytical capabilities. As the leading regulatory agency for ensuring...
- Bruker Biospin Corp, a manufacturer of scientific instruments, was awarded a firm fixed price purchase order by the Department of Health and Human Services Food and Drug Administration for $1,609,000. The contract calls for Bruker Biospin Corp to provide a 600 MHz Bruker nuclear magnetic resonance spectrometer to the agency's facility in Billerica, Massachusetts by December 31, 2022. No set-aside designation was used for this procurement. Bruker Corporation is the parent company of Bruker...
- This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
- <p>The National Institutes of Health National Heart Lung and Blood Institute awarded a $910,000 purchase order to Bruker Biospin Corp., a subsidiary of Bruker Corporation, to provide an NMR CONSOLE AVANCE NEO 600 MHZ. The place of performance is in Billerica, Massachusetts and the contract period runs from September 22, 2023 through January 22, 2024. The pricing structure is firm fixed price. No subcontractors were identified.</p>
- This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the provision of nuclear magnetic resonance (NMR) equipment and services. The contract has a ceiling value of $1,334,738.00 and a period of performance ending on July 31, 2017. The contract was awarded on a full and open competition basis, with no set-aside designation. Bruker Biospin Corp is a manufacturer of advanced...
- The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp. a $21,810 purchase order to provide helium fill maintenance services for a 600 MHz nuclear magnetic resonance spectrometer located in Billerica, Massachusetts. As the prime contractor, Bruker Biospin will perform the requested maintenance through December 2024 on the equipment, which is used to support the FDA's regulatory and research efforts. No subcontractors or set aside designations were...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, for the procurement of a 400MHz NMR spectrometer food screening system, under solicitation FDA-RFQ-CFSAN-2024-121654. The total ceiling value of the contract is $359,990.00, with a completion date of July 4, 2025. This award is not associated with a set-aside program. Bruker Biospin Corp is a manufacturer of scientific instruments and has a...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a manufacturer of scientific instruments, a $398,050.00 firm-fixed-price purchase order contract to provide an NMR 400 console upgrade and deuterium probe. The contract was not set aside. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support services to various U.S. federal government agencies. This award supports the FDA's...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $732,711.84 firm fixed price purchase order to Bruker Biospin Corp. of Billerica, Massachusetts for an NMR CONSOLE AVANCE NEO 500 MHZ. The contract has a period of performance starting on September 18, 2022 through September 17, 2023 for the place of performance in Billerica, MA. Bruker Biospin Corp. will provide an NMR CONSOLE AVANCE NEO 500 MHZ as the prime contractor for the HHS FDA under this purchase order contract.
Generated 11/28/23, 12:46 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $732.7k | 9/18/22 |